Spontaneous pituitary abnormalities and mammary hyperplasia in FVB/NCr mice: Implications for mouse modeling

Comparative Medicine

Volumn 53, Issue 4, 2003, Pages 424-432

  Wakefield, Lalage M ^a   Thordarson, Gudmundur ^b   Nieto, Ana I ^c   Shyamala, G ^d   Galvez, Jose J ^e   Anver, Miriam R ^f   Cardiff, Robert D ^e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TESTING REFINEMENT; ANIMAL TISSUE; ARTICLE; BREAST HYPOPLASIA; CONTROLLED STUDY; DNA MODIFICATION; GENETIC ASSOCIATION; GENETIC ENGINEERING; HYPOPHYSIS DISEASE; HYPOPHYSIS PARS DISTALIS; MAMMARY GLAND; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; TRANSGENIC MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HYPERPLASIA; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; PITUITARY DISEASES; PITUITARY GLAND;

EID: 0141813442     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ben Jonathan, N., J. L. Mershon, D. L. Allen, and R. W. Steinmetz. 1996. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr. Rev. 17:639-669.
2. Brisken, C., S. Kaur, T. E. Chavarria, N. Binart, R. L. Sutherland, R. A. Weinberg, P. A. Kelly, and C. J. Ormandy. 1999. Prolactin controls mammary gland development via direct and indirect mechanisms. Dev. Biol. 210:96-106.
3. Burrow, G. N., G. Wortzman, N. B. Rewcastle, R. C. Holgate, and K. Kovacs. 1981. Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N. Engl. J. Med. 304:156-158.
4. Capen, C. C., E. Karbe, U. Deschl, C. George, P.-G. Germann, C. Gopinath, J. F. Hardisty, J. Kanno, W. Kaufmann, G. Krinke, K. Kuttler, B. Kulwich, C. Landes, B. Lenz, L. Longeart, I. Paulson, E. Sander, and K. Tuch. 2001. Endocrine system. Pituitary gland, p. 270-283. In U. Mohr (ed.), International classification of rodent tumors. The mouse. Springer-Verlag, Berlin.
5. Cardiff, R. D., M. R. Anver, B.A. Gusterson, L. Hennighausen, R. A. Jensen, M. J. Merino, S. Rehm, J. Russo, F. A. Tavassoli, L. M. Wakefield, J. M. Ward, and J. E. Green. 2000. The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 19:968-988.
6. Clevenger, C. V. and T. L. Plank. 1997. Prolactin as an autocrine/ paracrine factor in breast tissue. J. Mammary. Gland. Biol. Neoplasia 2:59-68.
7. Felicio, L. S., J. F. Nelson, and C. E. Finch. 1980. Spontaneous pituitary tumorigenesis and plasma oestradiol in ageing female C57BL/6J mice. Exp. Gerontol. 15:139-143.
8. Gorska, A. E., H. Joseph, R. Derynck, H. L. Moses, and R. Serra. 1998. Dominant-negative interference of the transforming growth factor β type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice. Cell Growth Differ. 9:229-238.
9. Hankinson, S. E.,W. C. Willett, D. S. Michaud, J. E. Manson, G. A. Colditz, C. Longcope, B. Rosner, and F. E. Speizer. 1999. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. J. Natl. Cancer Inst. 91:629-634.
10. Hennighausen, L. and G. W. Robinson. 1998. Think globally, act locally: the making of a mouse mammary gland. Genes Dev. 12:449-455.
11. Huseby, R. A., M. J. Soares, and F. Talamantes. 1985. Ectopic pituitary grafts in mice: hormone levels, effects on fertility, and the development of adenomyosis uteri, prolactinomas, and mammary carcinomas. Endocrinology 116:1440-1448.
12. Kordon, E. C., R. A. McKnight, C. Jhappan, L. Hennighausen, G. Merlino, and G. H. Smith. 1995. Ectopic TGF beta 1 expression in the secretory mammary epithelium induces early senescence of the epithelial stem cell population. Dev. Biol. 168:47-61.
13. Kwa, H. G., M. Jong-Bakker, E. Engelsman, and F. J. Cleton. 1974. Plasma-prolactin in human breast cancer. Lancet 1:433-435.
14. Liebelt, A. G. 1994. Tumors of the pituitary gland, p. 527-547. In V. S. Turusov and U. Mohr (ed.), Pathology of tumours in laboratory animals, vol. II, tumors of the mouse. International Agency for Research on Cancer (IARC) Scientific Publications, Lyon.
15. Lloyd, R. V. 1990. Tumors of the pituitary gland, p. 499-537. In V. S. Turusov and U. Mohr (ed.), Pathology of tumours in laboratory animals, vol. I, tumors of the rat. International Agency for Research on Cancer (IARC) Scientific Publications, Lyon.
16. Mahler, J. F., W. Stokes, P. C. Mann, M. Takaoka, and R. R. Maronpot. 1996. Spontaneous lesions in aging FVB/N mice. Toxicol. Pathol. 24:710-716.
17. Markoff, E., P. Colosi, and F. Talamantes. 1981. Homologous radioimmunoassay for secreted mouse prolactin. Life Sci. 28:203-211.
18. Nieto, A. I., G. Shyamala, J. J. Galvez, G. Thordarson, L. M. Wakefield, and R. D. Cardiff. 2003. Persistent mammary hyperplasia in FVB/N mice. Comp. Med. 53:
19. Taketo, M., A. C. Schroeder, L. E. Mobraaten, K. B. Gunning, G. Hanten, R. R. Fox, T. H. Roderick, C. L. Stewart, F. Lilly, C. T. Hansen, and P. A Overbeek. 1991. FVB/N: an inbred mouse strain preferable for transgenic analyses. Proc. Natl. Acad. Sci. USA 88:2065-2069.
20. Vomachka, A. J., S. L. Pratt, J. A. Lockefeer, and N.D. Horseman. 2000. Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth. Oncogene 19:1077-1084.
21. Wang, T. C., R. D. Cardiff, L. Zukerberg, E. Lees, A. Arnold, and E. V. Schmidt. 1994. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669-671.
22. Welsch, C. W. and H. Nagasawa. 1977. Prolactin and murine mammary tumorigenesis: a review. Cancer Res. 37:951-963.
23. Wennbo, H., M. Gebre-Medhin, A. Gritli-Linde, C. Ohlsson, O. G. Isaksson, and J. Tornell. 1997. Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. J. Clin. Invest 100:2744-2751.
24. Yang, Y. A., O. Dukhanina, B. Tang, M. Mamura, J. J. Letterio, J. MacGregor, S. C. Patel, S. Khozin, Z. Y. Liu, J. Green, M. R. Anver, G. Merlino, and L. M. Wakefield. 2002. Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects. J. Clin. Invest 109:1607-1615.